Jasper Therapeutics, Inc.
SEC CIK 1788028 · JSPR · last insider filing 2026-02-10
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Mahal Jeetinder Singh | Director · See remarks | filed 2021–2026 |
| Martell RON | Director · President, CEO and Director | filed 2022–2026 |
| Wiggans Thomas G | Director | filed 2023–2025 |
| Lucas Svetlana | Director | filed 2024–2025 |
| Shizuru Judith Anne | Director | filed 2021–2025 |
| Emster Kurt VON | Director | filed 2021–2025 |
| Nolet Chris | Director | filed 2021–2025 |
| Kapoor Vishal | Director · President | filed 2020–2025 |
| Brun Scott C. | Director | filed 2023–2025 |
| French Anna Louise | Director | filed 2021–2024 |
| Venkataraman Balaji | Director · Chief Executive Officer | filed 2019–2024 |
| Lis William | Director · See Remarks | filed 2021–2023 |
| Klein Lawrence Otto | Director | filed 2021–2023 |
| Hoffen Howard I | Director | filed 2019–2021 |
| Eshelman Fredric N | Director | filed 2019–2019 |
| Mario Ernest | Director | filed 2019–2019 |
| Dolan Peter R | Director | filed 2019–2019 |
| Reicin Glenn | Director | filed 2019–2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Cross Herb | Chief Financial Officer | filed 2023–2026 |
| Tucker Edwin Jonathan | Chief Medical Officer | filed 2023–2025 |
| Heller Kevin N. | See Remarks | filed 2021–2022 |
| Clifford Kenneth F | Chief Financial Officer | filed 2019–2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.